Brooklyn Investment Group’s Organogenesis Holdings ORGO Stock Holding History

Brooklyn Investment Group’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,535	Closed	-$253K	–	1979
2025 Q4	$253K	Sell	48,535 -17,949	-27%	-$87K	0.01%	1193
2025 Q3	$244K	Hold	66,484	–	–	0.03%	509
2025 Q2	$243K	Buy	+66,484	New	+$248K	0.03%	516
2025 Q1	–	Sell	-705	Closed	-$2.26K	–	2856
2024 Q4	$2.26K	Buy	+705	New	+$2.37K	﹤0.01%	1429

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Brooklyn Investment Group's ORGO Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 48,535 shares — an estimated $253K sold.

Brooklyn Investment Group first reported a position in ORGO in Q4 2024 and held it in 4 quarters. The position peaked at $253K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Brooklyn Investment Group reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Brooklyn Investment Group sold 48,535 Organogenesis Holdings shares in Q1 2026, an estimated $253K.
Brooklyn Investment Group first reported a position in Organogenesis Holdings in Q4 2024 and held it in 4 quarters.
Brooklyn Investment Group's Organogenesis Holdings position peaked at $253K in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.